Natural compounds regulating MAPK-related signaling pathways: potential intervention strategies for gastric cancer
Abstract
Gastric cancer (GC) is a common malignant tumor of the digestive system, and its progression involves multiple molecular factors and signaling pathways. Dysregulation of mitogen-activated protein kinase (MAPK)-related signaling pathways is closely associated with the proliferation, invasion, metastasis, and drug resistance of GC. This review summarizes the major upstream factors associated with MAPK dysregulation, including Helicobacter pylori infection, genetic mutations, Epstein-Barr virus (EBV) infection, and epigenetic regulation. In addition, this review explores MAPK-related biological processes, including autophagy, oxidative stress, apoptosis, epithelial-mesenchymal transition (EMT), and cell cycle arrest. This paper focuses specifically on natural compounds capable of modulating ERK, JNK, and p38 MAPK-related signaling, as well as their interactions with other signaling networks, including PI3K/Akt, JAK/STAT3, and reactive oxygen species (ROS). Current evidence is primarily derived from preclinical studies; direct validation of target binding is limited, and significant gaps remain regarding pharmacokinetics, bioavailability, safety, and clinical translation. Therefore, further mechanistic and translational studies are needed to elucidate the therapeutic potential of natural compounds that modulate MAPK-related signaling pathways in GC.
Related
- Mechanobiology in Osteoarthritis: From Crosstalk of Mechanosensitive Signaling Pathways to the Intervention Mechanisms and Therapeutic Potential of Exercise.
- SESN2 promotes ferroptosis in bladder cancer by negatively regulating the NRF2/FSP1 signaling axis
- Bioactive compounds from Perilla frutescens modulate multiple cell death pathways and signaling networks in cancer therapy
- XDH Inhibits the Progression of Colorectal Cancer via Regulating Ferritinophagy Signaling.
- FKBP9 Drives Hepatocellular Carcinoma EMT by Regulating SEPT6 Transcription and Stability to Activate TGF-β Signaling.
BibTeX
@article{guo2026natural,
title = {{Natural compounds regulating MAPK-related signaling pathways: potential intervention strategies for gastric cancer}},
author = {Song Guo and Hongbao Wang and Youhui Wang and Wei Kong},
journal = {Frontiers in Pharmacology},
year = {2026},
month = nov,
doi = {10.3389/fphar.2026.1952502},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1952502},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Natural compounds regulating MAPK-related signaling pathways: potential intervention strategies for gastric cancer
AU - Song Guo
AU - Hongbao Wang
AU - Youhui Wang
AU - Wei Kong
PY - 2026
DA - 2026/11/02
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1952502
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1952502
AB - Gastric cancer (GC) is a common malignant tumor of the digestive system, and its progression involves multiple molecular factors and signaling pathways. Dysregulation of mitogen-activated protein kinase (MAPK)-related signaling pathways is closely associated with the proliferation, invasion, metastasis, and drug resistance of GC. This review summarizes the major upstream factors associated with MAPK dysregulation, including Helicobacter pylori infection, genetic mutations, Epstein-Barr virus (EBV) infection, and epigenetic regulation. In addition, this review explores MAPK-related biological processes, including autophagy, oxidative stress, apoptosis, epithelial-mesenchymal transition (EMT), and cell cycle arrest. This paper focuses specifically on natural compounds capable of modulating ERK, JNK, and p38 MAPK-related signaling, as well as their interactions with other signaling networks, including PI3K/Akt, JAK/STAT3, and reactive oxygen species (ROS). Current evidence is primarily derived from preclinical studies; direct validation of target binding is limited, and significant gaps remain regarding pharmacokinetics, bioavailability, safety, and clinical translation. Therefore, further mechanistic and translational studies are needed to elucidate the therapeutic potential of natural compounds that modulate MAPK-related signaling pathways in GC.
SN - 1663-9812
ER -